What agents effectively eradicate vancomycin‑resistant Enterococcus (VRE) in patients and on surfaces?

What Kills VRE: Antimicrobial and Environmental Eradication Strategies

For clinical VRE infections, linezolid 600 mg IV/PO every 12 hours is the first-line systemic agent across most infection sites, achieving microbiological cure in approximately 86% of cases, while uncomplicated urinary tract infections respond to oral fosfomycin 3 g as a single dose. 1, 2, 3

Systemic Antimicrobial Agents for VRE Infections

First-Line Options by Infection Site

Bacteremia and Serious Systemic Infections:

• Linezolid 600 mg IV or PO every 12 hours remains the preferred agent, with clinical cure rates of 81.4% and microbiological cure rates of 86.4%. 1, 2, 3
• High-dose daptomycin (10-12 mg/kg IV once daily) is the alternative bactericidal option, particularly when combined with β-lactams (ampicillin, ceftaroline, or meropenem) in patients with daptomycin MIC ≤2 mg/L, reducing 30-day mortality by approximately 77%. 1, 3
• Standard-dose daptomycin (6 mg/kg) is insufficient; doses of 10-12 mg/kg are required for optimal outcomes. 3
• Treatment duration: 10-14 days for uncomplicated bacteremia; 4-6 weeks for persistent bacteremia, endocarditis, or metastatic infection. 3

Pneumonia:

• Linezolid 600 mg IV every 12 hours is the recommended agent due to excellent lung penetration. 3
• Minimum treatment duration: 7 days. 3

Intra-Abdominal Infections:

• Linezolid 600 mg IV every 12 hours for monomicrobial VRE infections. 2, 3
• Tigecycline (100 mg IV loading dose, then 50 mg IV every 12 hours) is acceptable for polymicrobial intra-abdominal infections when bacteremia is absent. 2, 3
• Treatment duration: 5-7 days, guided by clinical response and source control adequacy. 3

Urinary Tract Infections

Uncomplicated VRE Cystitis (Oral Options):

• Fosfomycin 3 g PO as a single dose is first-line therapy, achieving high urinary concentrations that reliably eradicate VRE. 1, 3
• Nitrofurantoin 100 mg PO every 6 hours for 5-7 days is an effective alternative. 1, 3, 4
• High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg PO/IV every 8 hours can overcome ampicillin resistance due to high urinary concentrations exceeding the MIC, with clinical and microbiological eradication rates of 88.1% and 86%, respectively. 1, 3

Complicated VRE UTI or Pyelonephritis:

• Linezolid 600 mg IV or PO every 12 hours is the preferred systemic agent. 1, 3
• High-dose daptomycin 8-12 mg/kg IV daily can be considered, particularly when bacteremia is present. 3
• Treatment duration: 5-7 days. 3

Endocarditis

• Cardiac surgery consultation is mandatory for VRE endocarditis, as combined surgical and antimicrobial therapy improves survival. 3
• Minimum of 6 weeks of combination antimicrobial therapy is required. 2, 3
• Central venous catheters and other infection sources must be removed when treating VRE bacteremia. 2

Critical Pitfalls to Avoid

Tigecycline for Bacteremia:

• Never use tigecycline for VRE bacteremia despite in vitro susceptibility, as it yields poor serum concentrations due to large volume of distribution and is linked to high treatment failure rates. 1, 2, 3
• Tigecycline is reserved exclusively for intra-abdominal infections without bacteremia. 2, 3

Colonization vs. Infection:

• Differentiate VRE colonization from true infection before initiating anti-VRE therapy to prevent unnecessary antibiotic exposure and preserve treatment options. 1, 2, 4
• Treating asymptomatic bacteriuria or colonization unnecessarily promotes resistance and increases healthcare costs. 4

Monitoring Requirements:

• Monitor creatine kinase (CK) levels when using high-dose daptomycin, though meta-analysis showed no significantly increased risk of CK elevation with high-dose regimens. 3
• Monitor for serotonin syndrome symptoms every 4-6 hours during the first 72 hours when using linezolid, particularly in patients on serotonergic medications. 3

Environmental Surface Decontamination

Infection Control Measures:

• VRE can be transmitted indirectly by transient carriage on healthcare workers' hands or by contaminated environmental surfaces and patient-care equipment. 5
• Standard disinfection protocols using EPA-registered hospital-grade disinfectants effective against VRE are essential for environmental surface decontamination. 5
• Contact precautions including gowns and gloves should be implemented to prevent person-to-person transmission. 5

Algorithmic Approach to VRE Treatment

1. Confirm true infection vs. colonization through clinical assessment and appropriate cultures. 1, 2, 4
2. Obtain susceptibility testing—approximately 60% of E. faecium are vancomycin-resistant with variable ampicillin susceptibility. 3
3. Identify infection site:
   • Uncomplicated cystitis → Fosfomycin 3 g PO single dose 1, 3
   • Complicated UTI/pyelonephritis → Linezolid 600 mg IV/PO q12h 1, 3
   • Bacteremia → Linezolid 600 mg IV/PO q12h OR high-dose daptomycin 10-12 mg/kg IV daily ± β-lactam 1, 3
   • Pneumonia → Linezolid 600 mg IV q12h 3
   • Intra-abdominal (no bacteremia) → Linezolid 600 mg IV q12h OR tigecycline 2, 3
4. Remove infection sources: central lines, urinary catheters, surgical drainage of abscesses. 2
5. Consult infectious disease specialists for poor treatment response or when longer duration is considered. 3
6. Perform transesophageal echocardiography when bacteremia persists >72 hours or when central lines/ECMO cannulas are present to rule out endocarditis. 3